AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Evaluation of the Phantom X Implantable EMG Sensor System for Myoelectric Prosthesis Control

RecruitingNAAges 18 Years - anyAllPhantom Neuro Inc.
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The CYBORG Study is a first-in-human clinical investigation evaluating the safety and performance of the Phantom X System, an implantable electromyography (EMG) sensor array designed to provide control of upper-limb prostheses. The study will assess surgical feasibility, device function, signal quality, and the system's ability to support intuitive prosthetic control during functional tasks. Participants will undergo implantation of the Phantom X sensors and complete a series of in-clinic visits to assess functional performance of the Phantom X system. Patient-reported outcomes will also be collected at various timepoints.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Patient has a unilateral upper-limb difference (congenital or acquired) at the transradial or wrist level. 2. The patient currently uses a myoelectric prosthesis or is deemed a suitable candidate for fitting with a myoelectric prosthesis. 3. Patient is a suitable candidate for the implantation of the Phantom X sensor array as assessed by the implanting physician. 4. Patient is at least 18 years old and can provide written informed consent. 5. Patient is willing to comply with study protocol and make required study visits. 6. Patient received amputation โ‰ฅ 12 months prior to consent. Exclusion Criteria: 1. Patient has a significant cognitive deficit resulting in inability to follow study directions. 2. Patient has a neuro-muscular deficit and is unable to initiate substantial muscle contraction in the residual limb as determined by the implanting physician or investigator. 3. Patient has another medical condition, which, in the opinion of the Investigator, may cause him/her to be non-compliant with the protocol, confound the data interpretation, or is associated with a life expectancy insufficient to allow for the completion of study procedures and follow-up. 4. The patient has a planned medical procedure (e.g., surgery) during the study period that could interfere with compliance with study visits or assessments. 5. Patient has an allergy to anesthesia or other medication used for sedation in the study. 6. Patient has an active implantable device (e.g. cardiac pacemaker, neuromodulation device) that can potentially interfere with the performance of Phantom X system. 7. Patient may require an MRI during the study duration. 8. Implantation of the device poses a health risk to the patient as determined by the implanting physician. 9. Women who are breastfeeding, currently pregnant or planning to become pregnant during the duration of the study or have a positive urine pregnancy test at screening.
๐Ÿ’Š

What it tests

  • Phantom X multielectrode EMG sensor array implant for upper limb prosthesis control
๐Ÿ“

Where

2 sites
Cabrini Health Ltd
Malvern, Australia
ProMotion Prosthetics Pty Ltd
Moorabbin, Australia
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy